Secreted forms of β-amyloid precursor protein protect against ischemic brain injury

  • Virginia L. Smith-Swintosky
  • , L. Creed Pettigrew
  • , Susan D. Craddock
  • , Alan R. Culwell
  • , Russell E. Rydel
  • , Mark P. Mattson

Research output: Contribution to journalArticlepeer-review

206 Scopus citations

Abstract

The β-amyloid precursor protein (βAPP) is the source of the amyloid β- peptide that accumulates in the brain in Alzheimer's disease. A major processing pathway for βAPP involves an enzymatic cleavage within the amyloid β-peptide sequence that liberates secreted forms of βAPP (APP(s)s) into the extracellular milieu. We now report that postischemic administration of these APP(s)s intracerebroventricularly protects neurons in the CA1 region of rat hippocampus against ischemic injury. Treatment with APP(s)695 or APP(s)751 resulted in increased neuronal survival, and the surviving cells were functional as demonstrated by their ability to synthesize protein. These data provide direct evidence for a neuroprotective action of APP(s)s in vivo.

Original languageEnglish
Pages (from-to)781-784
Number of pages4
JournalJournal of Neurochemistry
Volume63
Issue number2
DOIs
StatePublished - Aug 1994

Funding

FundersFunder number
National Institute of Neurological Disorders and StrokeK08NS001505

    Keywords

    • Alzheimer's disease
    • Ischemia
    • Neuroprotection
    • β-Amyloid precursor protein

    ASJC Scopus subject areas

    • Biochemistry
    • Cellular and Molecular Neuroscience

    Fingerprint

    Dive into the research topics of 'Secreted forms of β-amyloid precursor protein protect against ischemic brain injury'. Together they form a unique fingerprint.

    Cite this